Sources: China to approve Qualcomm-NXP deal in next few days, but with conditions, as regulators fear merged company's dominance in areas like mobile payments
Wall Street Journal : Tweets: @lingling_wei Tweets: Lingling Wei / @lingling_wei : China's U-turn on Qualcomm coincides with Trump's U-turn on ZTE. Following Trump's pledge to save ZTE, Wang Qishan told foreign execs including one from Qualcomm its NXP deal stood a good chance of getting approved. w/@kubota_yoko @yoyominnie http://www.wsj.com/... via @WSJ
Context & Ripple Effects
Qualcomm's $47B push to buy NXP had cleared every other gate months ago — the EU and South Korean regulators signed off in January after Qualcomm agreed to competition-related changes — leaving Beijing as the lone holdout. In April, China was delaying reviews of both the NXP deal and Bain's Toshiba chip acquisition as leverage in the tariff fight, and the deal looked likely to die on the vine.
What changed is explicit reciprocity: after Trump pledged to save ZTE, Wang Qishan told foreign executives — including one from Qualcomm — that the NXP deal stood a good chance of approval, and the WSJ now reports sign-off within days, with conditions aimed at the merged company's potential dominance in mobile payments. The two U-turns mirror each other almost line for line.
First-order effects
- Qualcomm gets its final regulatory clearance, unblocking the last step toward closing the NXP acquisition — but the attached conditions give Chinese regulators a standing lever over the combined company's mobile-payments business.
- ZTE gains directly from the trade: Trump's rescue pledge is answered by Beijing greenlighting a marquee US semiconductor deal, converting a stalled antitrust file into diplomatic currency.
Second-order effects
- Mobile-payments conditions could force the merged Qualcomm-NXP to ring-fence NXP's secure-transaction chip business rather than bundle it with Qualcomm's handset dominance — shaping pricing and product integration in exactly the market regulators flagged.
- Other US-China deals held hostage in the same review queue, like Bain's bid for Toshiba's chip unit, gain a template: their fate now tracks the state of the broader trade negotiation, not the merits of the filings.
Third-order effects
- Antitrust review is becoming a reciprocal bargaining instrument between Washington and Beijing — approvals granted, delayed, or conditioned in lockstep with each side's trade concessions, as this ZTE-for-NXP swap shows.
- The signal to global chipmakers is that no major cross-border acquisition is complete until it survives geopolitics: even with EU, South Korean, and reportedly Chinese clearance, later reporting like Reuters finding sources close to the deal unaware of any actual approval shows how fragile 'imminent' sign-offs remain when they are political instruments first.
The trend: Semiconductor M&A approvals are being traded as currency in US-China negotiations, with each government's regulatory moves calibrated against the other's concessions.